SYAP1
Synapse-associated protein 1
Also known as: FLJ14495, PRO3113, SYAP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A49
- Gene
- SYAP1
- Ensembl
- ENSG00000169895
- Chromosome
- X
- Canonical length
- 352 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Golgi apparatus,Cytosol
OverviewNCBI Gene
Involved in several processes, including TORC2 signaling; cellular response to epidermal growth factor stimulus; and cellular response to peptide hormone stimulus. Located in several cellular components, including Golgi apparatus; cytoplasmic side of plasma membrane; and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
352 residues, UniProt reviewed canonical sequence.
>Q96A49|SYAP1
1 MFRGLSSWLG LQQPVAGGGQ PNGDAPPEQP SETVAESAEE ELQQAGDQEL LHQAKDFGNY
61 LFNFASAATK KITESVAETA QTIKKSVEEG KIDGIIDKTI IGDFQKEQKK FVEEQHTKKS
121 EAAVPPWVDT NDEETIQQQI LALSADKRNF LRDPPAGVQF NFDFDQMYPV ALVMLQEDEL
181 LSKMRFALVP KLVKEEVFWR NYFYRVSLIK QSAQLTALAA QQQAAGKEEK SNGREQDLPL
241 AEAVRPKTPP VVIKSQLKTQ EDEEEISTSP GVSEFVSDAF DACNLNQEDL RKEMEQLVLD
301 KKQEETAVLE EDSADWEKEL QQELQEYEVV TESEKRDENW DKEIEKMLQE ENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SYAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- liver: 28 nTPM
- bone marrow: 24 nTPM
- adrenal gland: 24 nTPM
- duodenum: 16 nTPM
- kidney: 15 nTPM
- parathyroid gland: 15 nTPM
Single-cell type
- neutrophils: 2,222 nCPM
- mast cells: 832 nCPM
- monocytes: 518 nCPM
- megakaryocyte-erythroid progenitors: 509 nCPM
- late spermatids: 458 nCPM
- esophageal apical cells: 435 nCPM
Immune cell
- neutrophil: 12 nTPM
- non-classical monocyte: 12 nTPM
- T-reg: 11 nTPM
- NK-cell: 10 nTPM
- gdT-cell: 9.9 nTPM
- eosinophil: 9.3 nTPM
Brain region
- choroid plexus: 31 nTPM
- white matter: 23 nTPM
- cerebral cortex: 22 nTPM
- thalamus: 22 nTPM
- hypothalamus: 21 nTPM
- medulla oblongata: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 1.16
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cellular response to epidermal growth factor stimulus
- cellular response to insulin stimulus
- cellular response to insulin-like growth factor stimulus
- cellular response to platelet-derived growth factor stimulus
- positive regulation of fat cell differentiation
- positive regulation of protein serine/threonine kinase activity
- regulation of short-term neuronal synaptic plasticity
- TORC2 signaling
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SYAP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SYAP1 as an antibody target. Whether an autoantibody or antibody against SYAP1 could matter depends on whether native SYAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SYAP1 is annotated at the cell surface, where native SYAP1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SYAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...